Similarly, AKT and 4EBP1, downstream targets of the PI3K/AKT/mTOR pathway, were inhibited by NT157, further highlighting the antineoplastic potential of this compound in lung cancer, since this signaling pathway is mutated or aberrantly activated in this disease40,41. The gene discussed is EIF4EBP1; the disease is lung carcinoma.